2186 — Luye Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapValue Trap

Annual balance sheet for Luye Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,406	5,510	5,544	6,106	6,503
Net Total Accounts Receivable
Net Total Receivables	1,807	2,388	2,266	2,592	2,780
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,970	10,397	10,786	10,703	13,308
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,339	4,594	4,909	5,155	6,050
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20,631	22,582	24,250	25,491	29,612
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,234	7,330	9,487	8,138	10,769
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	12,739	14,094	14,074	12,960	15,458
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	7,891	8,488	10,176	12,531	14,155
Total Liabilities & Shareholders' Equity	20,631	22,582	24,250	25,491	29,612
Total Common Shares Outstanding